Evidence Explorer · MS-N243 · Exercise and rehabilitation · cardiorespiratory fitness and cardiovascular-risk markers · Appraised November 5, 2026
A small randomized phase II trial found that 12 weeks of supervised high-intensity interval training improved peak oxygen uptake and several cardiovascular-risk markers in testicular-cancer survivors. It did not test heart attacks, stroke, recurrence or survival.
Evidence at a glance
- Benefit signal: Peak oxygen uptake improved by 3.7 mL/kg/min versus usual care, with favorable changes in several surrogate risk measures.
- Certainty: Low-to-moderate for short-term fitness because the randomized trial was small; low for long-term cardiovascular outcomes.
- Risk context: High-intensity training is not automatically suitable after cisplatin exposure or for people with cardiovascular, pulmonary or musculoskeletal limitations.
- Cancer-control relevance: No cancer-control evidence. Recurrence and survival were not trial endpoints.
What was studied
Sixty-three testicular-cancer survivors were randomized to 12 weeks of supervised high-intensity interval training or usual care; 61 completed post-intervention testing.
Attendance was reported as 99% and adherence to prescribed intensity as 98%, which supports feasibility in this selected study group.
What the study found
Peak oxygen uptake increased by 3.7 mL/kg/min relative to usual care (95% CI 2.4 to 5.1; p<0.001). Several body-composition and cardiovascular-risk markers also improved.
The prevalence of modifiable cardiovascular-risk factors was reported to fall by 20 percentage points. These were risk factors, not observed cardiovascular events.
What this does not establish
Short-term changes in fitness and surrogate markers cannot establish fewer heart attacks, strokes or deaths. The result may not generalize to people with major comorbidity, active treatment complications or limited access to supervision.
Safety and practical context
Cisplatin-treated survivors can have hypertension, dyslipidemia, kidney impairment, neuropathy or vascular risk. Baseline assessment and gradual progression are especially important.
Stop and seek assessment for exertional chest pain, syncope, sustained palpitations or unusual breathlessness. Trial intensity is not a self-prescribing target.
Questions for the care team
- Should blood pressure, lipids, kidney function or symptoms be assessed before vigorous training?
- Would moderate-intensity training achieve safer progress initially?
- Where can I access supervised rehabilitation familiar with cancer survivorship?
Sources and identifiers
Funding and conflicts: Not fully verified from the accessible abstract.
Source access and dates: Primary abstract was appraised; full adverse-event and conflict-of-interest details were not independently verified. Sources checked November 5, 2026. Last literature search November 5, 2026.
Educational evidence summary, not individualized medical advice. Exercise around cancer treatment should be adapted to symptoms, blood counts, bone health, cardiopulmonary status, surgical restrictions and the treating team’s guidance.
